Oncology Meeting Resources

In this section, you can find all available abstracts, presentations and webcasts on OncologyPRO.

Here below, you can search across all meeting resources by session title, presentation title, presenter or keyword. Results can then be refined by topic, event and publication date.

The use of these presentations is for personal educational purposes only.
ESMO thanks the authors for their generosity.




Format available

http://oncologypro.esmo.org/Meeting-Resourc...r-2017/Bone-Health-in-Breast-Cancer-Patients

Date: 22 Nov 2017
Presenter: N. Harbeck, DE
Resources: Presentation
Topics: Breast Cancer, Palliative and Supportive Care

http://oncologypro.esmo.org/Meeting-Resourc...17/Communicating-Bad-News-to-Cancer-Patients

Date: 22 Nov 2017
Presenter: L. Travado, PT
Resources: Presentation
Topics: Breast Cancer, Palliative and Supportive Care

http://oncologypro.esmo.org/Meeting-Resourc...ngress/Challenges-in-complex-pain-management

Date: 19 Nov 2017
Presenter: Alethea Yee
Topics: Palliative Care, Palliative and Supportive Care

http://oncologypro.esmo.org/Meeting-Resourc...7-Congress/Depression-in-early-stage-disease

Date: 19 Nov 2017
Presenter: Yosuke Uchitomi
Resources: Presentation, Webcast
Topics: Psychosocial Aspects of Cancer, Palliative and Supportive Care

http://oncologypro.esmo.org/Meeting-Resourc...is-of-the-PEMVITASTART-randomized-trial-417O

BackgroundVitamin B12 & folic acid supplementation (B12-FAS) reduces the incidence & severity of toxicity in pemetrexed based chemotherapy. It is recommended to initiate B12-FAS, 5-7 days before the 1st cycle.

Date: 19 Nov 2017
Presenter: Milind Baldi
Resources: Abstract, Presentation, Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Supportive Care, Non-Small-Cell Lung Cancer, Metastatic, Lung and other Thoracic Tumours, Palliative and Supportive Care

http://oncologypro.esmo.org/Meeting-Resourc...a-and-vomiting-CINV-in-Chinese-patients-501O

BackgroundAntiemetic guidelines universally recommend the combination of an NK1 receptor antagonist (NK1RA), a 5-HT3RA, and dexamethasone (DEX) for patients receiving highly emetogenic chemotherapy (HEC).

Date: 19 Nov 2017
Presenter: Yunpeng Yang
Resources: Abstract, Presentation, Webcast
Topics: Supportive Care, Palliative and Supportive Care

http://oncologypro.esmo.org/Meeting-Resourc...ematic-review-and-network-meta-analysis-502O

BackgroundRecent randomized clinical trials (RCTs) have demonstrated benefits of various pharmacologic interventions for cachexia in improving weight and appetite. However, their comparative efficacy and safety are not available.

Date: 19 Nov 2017
Presenter: manit Sae-Teaw
Resources: Abstract, Presentation, Webcast
Topics: Palliative Care, Palliative and Supportive Care

http://oncologypro.esmo.org/Meeting-Resourc...andomized-controlled-pilot-trial-VOLUME-503O

BackgroundChemotherapy-induced alopecia (CIA) is one of the most severe side effects breast cancer patients become distressed about. This study aimed to evaluate of the impact of a topical lotion on...

Date: 19 Nov 2017
Presenter: Juhee Cho
Resources: Abstract, Presentation, Webcast
Topics: Supportive Care, Palliative and Supportive Care

http://oncologypro.esmo.org/Meeting-Resourc...blind-placebo-controlled-clinical-trial-504O

BackgroundPhlebitis is a very common side effect of continuous intravenous infusion of 5-fluorouracil via the peripheral veins. We evaluated the preventive effects of topical steroid application on...

Date: 19 Nov 2017
Presenter: Yoko Hamabe
Resources: Abstract, Presentation, Webcast
Topics: Supportive Care, Palliative and Supportive Care

http://oncologypro.esmo.org/Meeting-Resourc...on-chronic-toxicity-and-quality-of-life-LBA7

BackgroundPD-1 inhibitors are breakthrough treatments in many malignancies. Tumour responses are often durable, and some patients experience long term disease control and potentially cure.

Date: 19 Nov 2017
Presenter: Johnathan Man
Resources: Abstract, Presentation, Webcast
Topics: Complications of Treatment, Cancer Immunology and Immunotherapy, Palliative and Supportive Care